Nuvectra® to Participate in Two Upcoming Investor Conferences
12 Junho 2019 - 5:05PM
Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical
device company, announced today that members of management are
scheduled to participate in two upcoming investor conferences in
New York, NY.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Event: |
|
|
|
|
Raymond James 2019 Life Sciences and MedTech
Conference |
|
|
|
|
Date: |
|
|
|
|
Tuesday, June 18, 2019 |
|
|
|
|
Time: |
|
|
|
|
11:30 a.m. ET |
|
|
|
|
Location: |
|
|
|
|
Lotte New York Palace Hotel |
|
|
|
|
Format: |
|
|
|
|
Presentation & 1x1 Meetings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Event: |
|
|
|
|
JMP Securities Life Sciences Conference |
|
|
|
|
Date: |
|
|
|
|
Wednesday, June 19, 2019 |
|
|
|
|
Time: |
|
|
|
|
2:00 p.m. ET |
|
|
|
|
Location: |
|
|
|
|
The St. Regis New York |
|
|
|
|
Format: |
|
|
|
|
Presentation & 1x1 Meetings |
|
|
|
|
|
|
|
|
|
|
Webcasts of the Company’s presentations will be
available by visiting the investor relations section of Nuvectra’s
website at www.nuvectramed.com. Webcast replays of the
presentations will be available for 90 days.
About Nuvectra Corporation
Nuvectra® is a neurostimulation company committed to helping
physicians improve the lives of people with chronic conditions. The
Algovita® Spinal Cord Stimulation (SCS) System is our first
commercial offering and is CE marked and FDA approved for the
treatment of chronic intractable pain of the trunk and/or limbs.
Our innovative technology platform also has capabilities under
development to support other indications such as sacral
neuromodulation (SNM) for the treatment of overactive bladder, and
deep brain stimulation (DBS) for the treatment of Parkinson’s
Disease. Visit the Nuvectra website at www.nuvectramed.com.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company Contacts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor Contacts: |
Nuvectra Corporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Ruth Group |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jennifer Kosharek |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tram Bui |
(214) 474-3107 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(646) 536-7035 |
jkosharek@nuvectramed.com |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
investors@nuvectramed.com |
Nuvectra (NASDAQ:NVTR)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Nuvectra (NASDAQ:NVTR)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
Notícias em tempo-real sobre Nuvectra Corporation da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de